Ireland

--:--IST

Latest

Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide

Subscribe

Registers› Irish medicines

Medicines register · Ireland

Every medicine authorised for the Irish market

The Health Products Regulatory Authority's full list of authorised products — brand, active substance, licence holder, licence number and market status. Filter it, cite it, and take it away as a file.

Source: HPRA open dataset ("Authorised or Transfer Pending Products"), CC BY 4.0. Complete coverage — all 10,296 authorised products are in this register. Synced 08 Oct 2026, 03:31 UTC

Narrow the register Reset

Search within results

Matches brand name, active substance, licence holder and licence number.

Browse by first letter

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

Medicine

Active substance

Licence holder

Status

Alecensa 150 mg hard capsules EU/1/16/1169/001

Alectinib hydrochloride

Roche Registration GmbH

—

Avastin 25 mg/ml concentrate for solution for infusion EU/1/04/300/001-002

Bevacizumab

Roche Registration GmbH

—

Avastin 25 mg/ml Concentrate for solution for infusion EU/1/04/300/1-2

Bevacizumab

Roche Registration Limited

—

CellCept 1 g/5 ml Powder for oral suspension EU/1/96/005/006

Mycophenolate mofetil

Roche Registration GmbH

—

CellCept 250 mg Capsule, hard EU/1/96/005/001

Mycophenolate mofetil

Roche Registration GmbH

—

CellCept 250 mg Capsule, hard EU/1/96/005/003

Mycophenolate mofetil

Roche Registration GmbH

—

CellCept 250 mg hard capsules EU/1/96/005/007

Mycophenolate mofetil

Roche Registration GmbH

—

CellCept 500 mg Film-coated tablet EU/1/96/005/002

Mycophenolate mofetil

Roche Registration GmbH

—

CellCept 500 mg Film-coated tablet EU/1/96/005/004

Mycophenolate mofetil

Roche Registration GmbH

—

CellCept 500 mg Powder for concentrate for solution for infusion EU/1/96/005/005

Mycophenolate mofetil

Roche Registration GmbH

—

Columvi 10 mg concentrate for solution for infusion EU/1/23/1742/002

Glofitamab

Roche Registration GmbH

—

Columvi 2.5 mg concentrate for solution for infusion EU/1/23/1742/001

Glofitamab

Roche Registration GmbH

—

Cotellic 20 mg film-coated tablets EU/1/15/1048/001

Cobimetinib hemifumarate

Roche Registration GmbH

—

Enspryng 120 mg solution for injection in pre-filled syringe EU/1/21/1559/001

Satralizumab

Roche Registration GmbH

—

Erivedge 150 mg hard capsules EU/1/13/848/001

Vismodegib

Roche Registration GmbH

—

Esbriet 267 mg film-coated tablets EU/1/11/667/012-017

Pirfenidone

Roche Registration Limited

—

Esbriet 801 mg film-coated tablets EU/1/11/667/018-019

Pirfenidone

Roche Registration Limited

—

Evrysdi 0.75 mg/mL powder for oral solution EU/1/21/1531/001

Risdiplam

Roche Registration GmbH

—

Evrysdi 5 mg film-coated tablets EU/1/21/1531/002

Risdiplam

Roche Registration GmbH

—

Fuzeon EU/1/03/252/001

Enfuvirtide

Roche Registration GmbH

Not marketed

Gazyvaro 1,000 mg concentrate for solution for infusion EU/1/14/937/001

Obinutuzumab

Roche Registration GmbH

—

Hemlibra 150 mg/mL solution for injection EU/1/18/1271/002-005

Emicizumab

Roche Registration GmbH

—

Hemlibra 30 mg/mL solution for injection EU/1/18/1271/001

Emicizumab

Roche Registration GmbH

—

Hemlibra 30 mg/mL solution for injection EU/1/18/1271/006

Emicizumab

Roche Registration GmbH

—

Herceptin 150 mg powder for concentrate for solution for infusion EU/1/00/145/001

Trastuzumab

Roche Registration GmbH

—

Herceptin 600 mg solution for injection in vial EU/1/00/145/002

Trastuzumab

Roche Registration GmbH

—

Itovebi 3 mg film-coated tablets EU/1/25/1942/001

Inavolisib

Roche Registration GmbH

—

Itovebi 9 mg film-coated tablets EU/1/25/1942/002

Inavolisib

Roche Registration GmbH

—

Kadcyla 100 mg powder for concentrate for solution for infusion EU/1/13/885/001

Trastuzumab emtansine

Roche Registration GmbH

—

Kadcyla 160 mg powder for concentrate for solution for infusion EU/1/13/885/002

Trastuzumab emtansine

Roche Registration GmbH

—

Lunsumio 1 mg concentrate for solution for infusion EU/1/22/1649/001

Mosunetuzumab

Roche Registration GmbH

—

Lunsumio 30 mg concentrate for solution for infusion EU/1/22/1649/002

Mosunetuzumab

Roche Registration GmbH

—

Lunsumio 45 mg solution for injection EU/1/22/1649/004

Mosunetuzumab

Roche Registration GmbH

—

Lunsumio 5 mg solution for injection EU/1/22/1649/003

Mosunetuzumab

Roche Registration GmbH

—

MabThera 100 mg concentrate for solution for infusion EU/1/98/067/001

Rituximab

Roche Registration GmbH

—

MabThera 1400 mg concentrate for solution for infusion EU/1/98/067/003

Rituximab

Roche Registration GmbH

—

MabThera 1600 mg concentrate for solution for infusion EU/1/98/067/004

Rituximab

Roche Registration GmbH

—

MabThera 500 mg concentrate for solution for infusion EU/1/98/067/002

Rituximab

Roche Registration GmbH

—

Madopar 100 mg/25 mg dispersible tablets PA2307/004/003

Levodopa, Benserazide

Roche Products (Ireland) Limited

Marketed

Madopar 200 mg/50 mg hard capsules PA2307/004/001

Levodopa, Benserazide

Roche Products (Ireland) Limited

Marketed

Madopar 50 mg/12.5 mg dispersible tablets PA2307/004/002

Levodopa, Benserazide

Roche Products (Ireland) Limited

Marketed

Mircera 100 micrograms/0.3 ml solution for injection in pre-filled syringe EU/1/07/400/10

Methoxy peg-epoetin beta

Roche Registration GmbH

—

Mircera 120 micrograms/0.3 ml solution for injection in pre-filled syringe EU/1/07/400/20

Methoxy peg-epoetin beta

Roche Registration GmbH

—

Mircera 150 micrograms/0.3 ml solution for injection in pre-filled syringe EU/1/07/400/11

Methoxy peg-epoetin beta

Roche Registration GmbH

—

Mircera 200 micrograms/0.3 ml solution for injection in pre-filled syringe EU/1/07/400/12

Methoxy peg-epoetin beta

Roche Registration GmbH

—

Mircera 250 micrograms/0.3 ml solution for injection in pre-filled syringe EU/1/07/400/13

Methoxy peg-epoetin beta

Roche Registration GmbH

—

Mircera 30 micrograms/0.3 ml solution for injection in pre-filled syringe EU/1/07/400/17

Methoxy peg-epoetin beta

Roche Registration GmbH

—

Mircera 360 micrograms/0.6 ml solution for injection in pre-filled syringe EU/1/07/400/21

Methoxy peg-epoetin beta

Roche Registration GmbH

—

Mircera 50 micrograms/0.3 ml solution for injection in pre-filled syringe EU/1/07/400/008

Methoxy peg-epoetin beta

Roche Registration GmbH

—

Mircera 75 micrograms/0.3 ml solution for injection in pre-filled syringe EU/1/07/400/009

Methoxy peg-epoetin beta

Roche Registration GmbH

—

Cite this view

Priya Life Science (2026). Irish Medicines Register, filtered. Derived from the HPRA open dataset. Retrieved 8 October 2026. https://priyalifescience.com/medicines

Download this register

GET /api/export.php?register=medicines-ie&format=csv Try the JSON export →

Regulatory information only — not medical advice. For the authoritative record see the HPRA register directly.